ArticleCureus2024
Peripartum Cardiomyopathy and Takotsubo Cardiomyopathy: Rare Contributors to Cardiac Causes of Maternal Mortality.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pregnancy-Associated Takotsubo Syndrome: A Narrative Review of the Literature.Journal of clinical medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Peripartum cardiomyopathy (PPCM) and takotsubo cardiomyopathy (TCM) are cardiac conditions that can occur in the peripartum period. They have distinct characteristics and incidence rates; although rare, both contribute to the second leading cause of all-cause maternal mortality in the state of Missouri. PPCM can lead to heart failure, and TCM can cause acute arrhythmias leading to sudden cardiac death in otherwise healthy individuals. Our patient developed PPCM and TCM, which led to myocardial infarction, resulting in anoxic brain injury at 10 months postpartum. This case presentation demonstrates the need to consider pregnancy-related conditions up to 12 months postpartum. We postulate that the cardiomyopathies could have presented as early as five to eight weeks postpartum. Had our patient received screening for cardiac disease, resulting in earlier diagnosis and treatment, she may still be alive today. Increased surveillance and suspicion of cardiac diseases are crucial to reducing early and late postpartum mortality. Our patient presented to the ER for a headache three days before developing cardiac arrest. Our recommendation would be to screen any asymptomatic woman up to 12 months postpartum with an electrocardiogram and brain natriuretic peptide and compare the results to the baseline, if available. If any results from the screening tests are abnormal, clinicians should further investigate with troponin levels and echocardiography. We recommended reporting this case to the Missouri Maternal Mortality Review Committee and a hospital autopsy be performed for further investigation and contribute to our understanding of high maternal deaths in the state.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.